LATAM Non-Viral Transfection Reagent Market Size & Outlook, 2026-2034

LATAM Non-Viral Transfection Reagent Market Insights

As highlighted in Reed Intelligence analysis, the LATAM Non-Viral Transfection Reagent Market, valued at USD 104.65 Million in 2025, is estimated to achieve USD 255.48 Million by 2034.
The market is estimated to grow at a CAGR of 10.43% spanning 2026 to 2034.
By market size, Lipid-Based Transfection Reagents led the Product Type category in 2025.
The Product Type segment led by Peptide-Based Transfection Reagents is estimated to post the fastest growth, sustaining its position as the most lucrative during the forecast timeframe.

Other Key Findings

LATAM held 7.37% share of the global Non-Viral Transfection Reagent Market size in 2025.
United States is expected to remain the largest contributor to the global market size by 2034.
By 2034, Argentina is anticipated to record the highest growth in LATAM, with the market size expected to reach USD 29.28 Million.

Report Summary

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 104.65 Million
Market Size In 2034	USD 255.48 Million
Largest segment	Lipid-Based Transfection Reagents
Units	Revenue in USD Million
CAGR	10.43% (2026-2034)
Segmnetation Covered
LATAM	Brazil Mexico Argentina Colombia Chile
Product Type	Lipid-Based Transfection Reagents Polymer-Based Transfection Reagents Nanoparticle-Based Transfection Reagents Peptide-Based Transfection Reagents Others
Application	Biomedical Research Gene Therapy Development Protein Production Cancer Research Drug Discovery Others
End User	Pharmaceutical and Biotechnology Companies Academic and Research Institutes Contract Research Organizations Hospitals and Diagnostic Laboratories
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

LATAM Non-Viral Transfection Reagent Market Country 2026-2034 (USD Million)

LATAM	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Brazil	XX.x	XX.x	XX.x	47.09	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Mexico	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Argentina	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Colombia	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Chile	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

LATAM Non-Viral Transfection Reagent Market Product Type 2026-2034 (USD Million)

Product Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Lipid-Based Transfection Reagents	XX.x	XX.x	XX.x	43.62	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Polymer-Based Transfection Reagents	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Nanoparticle-Based Transfection Reagents	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Peptide-Based Transfection Reagents	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

LATAM Non-Viral Transfection Reagent Market Application 2026-2034 (USD Million)

Application	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Biomedical Research	XX.x	XX.x	XX.x	31.53	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Gene Therapy Development	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Protein Production	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Cancer Research	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Drug Discovery	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

LATAM Non-Viral Transfection Reagent Market End User 2026-2034 (USD Million)

End User	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Pharmaceutical and Biotechnology Companies	XX.x	XX.x	XX.x	51.33	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Academic and Research Institutes	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Contract Research Organizations	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Hospitals and Diagnostic Laboratories	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.